BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2018
View Archived Issues
CTA approval for ARGX-112 triggers milestone payment to Argenx
Read More
ImmunoCellular Therapeutics achieves milestone in Stem-to-T-Cell program
Read More
Phase I trial of TQB-2450 approved and initiated in China
Read More
RubrYc Therapeutics closes series A financing
Read More
Adynxx presents promising phase II data from ADYX-004 study of brivoligide
Read More
Novel mutation in SMARCE1 gene discovered in OAFNS
Read More
Humanetics obtains NIAID grant to support development of BIO-300 as a medical countermeasure
Read More
Beijing Tiancheng Pharma divulges new FGFR inhibitors
Read More
BMS and Harvard enter fibrosis research collaboration
Read More
University of Ottawa, Lcb Pharma patent nucleoside and nucleotide analogues
Read More
Patient recruitment ongoing in phase I study of BIIB-095
Read More
Novel dopamine beta-hydroxylase inhibitors identified at BIAL-Portela & Ca.
Read More
Dinutuximab plus irinotecan well tolerated in part 1 of phase II/III small cell lung cancer study
Read More
Emergent BioSolutions completes MRP for BioThrax in five E.U. countries
Read More
Deerfield leads investment in Sollis Therapeutics
Read More
Galapagos announces plans for phase III program of GLPG-1690 in IPF
Read More
New PIEZO1 gene mutations associated with nonimmune hydrops fetalis
Read More
STK25 identified as a therapeutic target for NAFLD
Read More
FDA finalizes guidance on NGS-based tests
Read More
Phase I/II study of DNA vaccine for hypertension begins in Australia
Read More
GSK to transfer rare disease gene therapy portfolio to Orchard Therapeutics
Read More
PCSK7, a potential therapeutic target for metabolic disorders
Read More
FDA approves use of IDx-DR to detect diabetic retinopathy
Read More
